Author

Maxime Kempers

The Netherlands Cancer InstituteORCID 0000-0002-4457-8408Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Maxime Kempers1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Bram van den BroekiD· 1 shared Eliza Mari Kwesi‐MaliepaardiD· 1 shared Elselien FrijlinkiD· 1 shared Elzo de WitiD· 1 shared Fred van LeeuweniD· 1 shared Heinz JacobsiD· 1 shared Jannie G. BorstiD· 1 shared Liesbeth HoekmaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bram van den BroekORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyScience AdvancesPeer-reviewedDec 12, 2025

Histone methyltransferase DOT1L maintains identity and restricts cytotoxic potential of CD8 T cells

Muddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam…·Fred van Leeuwen

This study shows that DOT1L maintains CD8 T cell identity and restricts their cytotoxic potential by preventing NK-cell features and enhancing anti-tumor reactivity.

5 citations

mousebulk RNA-seq

𝕏 PostBluesky